Encoded self-assembling chemical libraries

Abstract

The isolation of molecules capable of high-affinity and specific binding to biological targets is a central problem in chemistry, biology and pharmaceutical sciences. Here we describe the use of encoded self-assembling chemical (ESAC) libraries for the facile identification of molecules that bind macromolecular targets. ESAC technology uses libraries of organic molecules linked to individual oligonucleotides that mediate the self-assembly of the library and provide a code associated with each organic molecule. After panning ESAC libraries on the biomolecular target of interest, the 'binding code' of the selected compounds can be 'decoded' by a number of experimental techniques (e.g., hybridization on oligonucleotide microarrays). The potential of this technology was demonstrated by the affinity maturation (>40-fold) of binding molecules to human serum albumin and bovine carbonic anhydrase, leading to binders with dissociation constants in the nanomolar range.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Figure 1: Schematic representation of ESAC libraries.
Figure 2: Decoding of model ESAC selections against streptavidin.
Figure 3: Microarray decoding of ESAC affinity maturation selections against HSA and CA.
Figure 4: Affinity measurements of ligands to HSA and CA, obtained by ESAC selections.
Figure 5: Isothermal titration calorimetry profiles of CA binders.

References

  1. 1

    Winter, G., Griffiths, A.D., Hawkins, R.E. & Hoogenboom, H.R. Making antibodies by phage display technology. Annu. Rev. Immunol. 12, 433–455 (1994).

  2. 2

    Kohler, G. & Milstein, C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256, 495–497 (1975).

  3. 3

    Gold, L. Oligonucleotides as research, diagnostic, and therapeutic agents. J. Biol. Chem. 270, 13581–13584 (1995).

  4. 4

    Ramstrom, O. & Lehn, J.M. Drug discovery by dynamic combinatorial libraries. Nat. Rev. Drug Discov. 1, 26–36 (2002).

  5. 5

    Schreiber, S.L. Target-oriented and diversity-oriented organic synthesis in drug discovery. Science 287, 1964–1969 (2000).

  6. 6

    Otto, S., Furlan, R.L. & Sanders, J.K. Dynamic combinatorial chemistry. Drug Discov. Today 7, 117–125 (2002).

  7. 7

    Pellecchia, M., Sem, D.S. & Wuthrich, K. NMR in drug discovery. Nat. Rev. Drug Discov. 1, 211–219 (2002).

  8. 8

    Erlanson, D.A. et al. In situ assembly of enzyme inhibitors using extended tethering. Nat. Biotechnol. 21, 308–314 (2003).

  9. 9

    Griffiths, A.D. et al. Isolation of high affinity human antibodies directly from large synthetic repertoires. EMBO J. 13, 3245–3260 (1994).

  10. 10

    McCafferty, J., Griffiths, A.D., Winter, G. & Chiswell, D.J. Phage antibodies: filamentous phage displaying antibody variable domains. Nature 348, 552–554 (1990).

  11. 11

    Shuker, S.B., Hajduk, P.J., Meadows, R.P. & Fesik, S.W. Discovering high-affinity ligands for proteins: SAR by NMR. Science 274, 1531–1534 (1996).

  12. 12

    Maly, D.J., Choong, I.C. & Ellman, J.A. Combinatorial target-guided ligand assembly: identification of potent subtype-selective c-Src inhibitors. Proc. Natl. Acad. Sci. USA 97, 2419–2424 (2000).

  13. 13

    Hermanson, G.T. Bioconjugate Techniques (Academic Press, San Diego, 1996).

  14. 14

    Josephson, S., Lagerholm, E. & Palm, G. Automatic synthesis of oligodeoxynucleotides and mixed oligodeoxynucleotides using the phosphoamidite method. Acta Chem. Scand. B 38, 539–545 (1984).

  15. 15

    Velculescu, V.E., Zhang, L., Vogelstein, B. & Kinzler, K.W. Serial analysis of gene expression. Science 270, 484–487 (1995).

  16. 16

    Epps, D.E., Raub, T.J. & Kezdy, F.J. A general, wide-range spectrofluorometric method for measuring the site-specific affinities of drugs toward human serum albumin. Anal. Biochem. 227, 342–350 (1995).

  17. 17

    Scozzafava, A. et al. Carbonic anhydrase inhibitors. Synthesis of water-soluble, topically effective, intraocular pressure-lowering aromatic/heterocyclic sulfonamides containing cationic or anionic moieties: is the tail more important than the ring? J. Med. Chem. 42, 2641–2650 (1999).

  18. 18

    Pocker, Y. & Stone, J.T. The catalytic versatility of erythrocyte carbonic anhydrase. 3. Kinetic studies of the enzyme-catalyzed hydrolysis of p-nitrophenyl acetate. Biochemistry 6, 668–678 (1967).

  19. 19

    Carotti, A., Raguseo, C., Campagna, F., Langridge, R. & Klein, T.E. Inhibition of carbonic anhydrase by substituted benzenesulfonamides. A reinvestigation by QSAR and molecular graphics analysis. Quantitative Structure-Activity Relationships 8, 1–10 (1989).

  20. 20

    Brenner, S. & Lerner, R.A. Encoded combinatorial chemistry. Proc. Natl. Acad. Sci. USA 89, 5381–5383 (1992).

  21. 21

    Doyon, J.B., Snyder, T.M. & Liu, D.R. Highly sensitive in vitro selections for DNA-linked synthetic small molecules with protein binding affinity and specificity. J. Am. Chem. Soc. 125, 12372–12373 (2003).

  22. 22

    Hawkins, R.E., Russell, S.J. & Winter, G. Selection of phage antibodies by binding affinity. Mimicking affinity maturation. J. Mol. Biol. 226, 889–896 (1992).

  23. 23

    Morgan, G.T. Alfred Werner. J. Chem. Soc. 117, 1639–1648 (1920).

  24. 24

    Jencks, W.P. On the attribution and additivity of binding energies. Proc. Natl. Acad. Sci. USA 78, 4046–4050 (1981).

  25. 25

    Fersht, A. Enzyme Structure and Mechanism, edn. 2 (Freeman, New York, 1990).

  26. 26

    Hajduk, P.J., Meadows, R.P. & Fesik, S.W. Discovering high-affinity ligands for proteins. Science 278, 497–499 (1997).

  27. 27

    Rye, H.S. et al. Stable fluorescent complexes of double-stranded DNA with bis-intercalating asymmetric cyanine dyes: properties and applications. Nucleic Acids Res. 20, 2803–2812 (1992).

  28. 28

    Neri, D., Momo, M., Prospero, T. & Winter, G. High-affinity antigen binding by chelating recombinant antibodies (CRAbs). J. Mol. Biol. 246, 367–373 (1995).

  29. 29

    Fattorusso, R. et al. NMR structure of the human oncofoetal fibronectin ED-B domain, a specific marker for angiogenesis. Structure 7, 381–390 (1999).

  30. 30

    Scheuermann, J., Volonterio, A., Zerbe, O., Zanda, M. & Neri, D. Discovery and investigation of lead compounds as binders to the extra-domain B of the angiogenesis marker, fibronectin. Drug Dev. Res. 58, 268–282 (2003).

  31. 31

    Strobel, S.A., Doucette-Stamm, L.A., Riba, L., Housman, D.E. & Dervan, P.B. Site-specific cleavage of human chromosome 4 mediated by triple-helix formation. Science 254, 1639–1642 (1991).

  32. 32

    Cuenoud, B. & Schepartz, A. Altered specificity of DNA-binding proteins with transition metal dimerization domains. Science 259, 510–513 (1993).

  33. 33

    Clackson, T. & Wells, J.A. A hot spot of binding energy in a hormone-receptor interface. Science 267, 383–386 (1995).

  34. 34

    Gadek, T.R. et al. Generation of an LFA-1 antagonist by the transfer of the ICAM-1 immunoregulatory epitope to a small molecule. Science 295, 1086–1089 (2002).

Download references

Acknowledgements

This work was supported by the ETH Zürich, the Swiss National Science Foundation, the Bundesamt für Bildung und Wissenschaft/EU (STROMA Project) and Philogen. S.M. has been the recipient of a Boehringer-Ingelheim bursary and of an ETH Zürich bursary (special grant: ESACHEL). C.E.D. is a recipient of a bursary from the Roche Research Foundation. We are grateful to J. Sobek and R. Schlapbach for access to instrumentation and help with the microarray technology, and to R. Brunisholz, W. Amrein, O. Scheidegger, O. Greter, P. Hunziker and S. Chesnov for analytical assistance. We thank G. Guarda for help in decoding by sequencing, and R. Buff, O. Schärer and members of the Neri group for helpful discussions.

Author information

Correspondence to Dario Neri.

Ethics declarations

Competing interests

ESACHEL technology is covered by a patent application, which was licensed from ETH Zurich to Philogen S.r.l. under a share of revenues agreement. D.N. owns shares of Philogen and consults for this company. Since August 2003, S.M. and J.S. have received a salary from Philogen. The company also pays for reagents and overhead for ETH Zurich.

Supplementary information

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Melkko, S., Scheuermann, J., Dumelin, C. et al. Encoded self-assembling chemical libraries. Nat Biotechnol 22, 568–574 (2004). https://doi.org/10.1038/nbt961

Download citation

Further reading